AXION BIOSYSTEMS HOLDING UK LIMITED

Executive Summary

AXION BIOSYSTEMS HOLDING UK LIMITED shows a fragile financial condition characterized by minimal net assets and high current liabilities owed to group companies. While compliant with filings and audited cleanly, its liquidity position is strained. Strengthening equity and improving intra-group financing terms are key steps to enhance financial health.

View Full Analysis Report →
4 officers

BRADLEY, Julien

Correspondence address
8 King Edward Street, Oxford, United Kingdom, OX1 4HL
Role ACTIVE
director
Date of birth
January 1976
Appointed on
31 January 2024
Nationality
American
Occupation
Director

SHEIKH, Saad Saadat

Correspondence address
8 King Edward Street, Oxford, United Kingdom, OX1 4HL
Role ACTIVE
director
Date of birth
October 1986
Appointed on
10 August 2023
Nationality
British
Occupation
Emea Finance Director

ROSS, James

Correspondence address
1819 Peachtree Road Ne St 250, Atlanta, Ga, United States, 30309
Role ACTIVE
director
Date of birth
September 1978
Appointed on
23 December 2021
Resigned on
31 January 2024
Nationality
American
Occupation
Chief Technology Officer

STOCKLI MAYER, Nicole

Correspondence address
1819 Peachtree Road Ne St 250, Atlanta, Ga, United States, 30309
Role ACTIVE
director
Date of birth
February 1979
Appointed on
23 December 2021
Resigned on
10 August 2023
Nationality
American
Occupation
Chief Financial Officer


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company